Chair, CEO

Executive Vice President and Chief Financial Officer

Dulaglutide Market to Expand at a 7.5% CAGR by 2029, Reaching US $5.97 Billion

Lilly’s Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment

FDA’s Lost Leaders: Where Are They Now?

These 3 Obesity Drug Stocks Are Set to Soar This Fall and Beyond

Senior UX Researcher

Eli Lilly and Company is a global healthcare leader dedicated to improving lives through innovative medicines. The Senior UX Researcher will play a critical role in shaping the LillyDirect platform by conducting research to uncover actionable insights and enhance the patient and provider experience.

Sign up with Google

Sign in with Google